A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT03105128 · COMPLETED
Trial details
- NCT number
- NCT03105128
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2020-11-09
- Enrollment
- 931
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.